JEFFS ROGER 4
4 · Axsome Therapeutics, Inc. · Filed Aug 29, 2025
Insider Transaction Report
Form 4
JEFFS ROGER
Director
Transactions
- Sale
Common Stock
2025-08-27$122.30/sh−20,000$2,446,000→ 110,974 total - Sale
Common Stock
2025-08-28$121.60/sh−20,000$2,432,000→ 90,974 total - Sale
Common Stock
2025-08-29$121.27/sh−20,000$2,425,400→ 70,974 total
Footnotes (5)
- [F1]Represents the sale of underlying shares of previously exercised stock options.
- [F2]Such transaction was pursuant to a pre-approved 10b5-1 plan.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.74 and $123.56.
- [F4]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.75 and $122.47.
- [F5]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.02 and $122.28.